SIMPLEX TRADING, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$57
-89.2%
8,064
-87.3%
0.00%
Q1 2023$528
+14.8%
63,313
+58.0%
0.00%
-100.0%
Q4 2022$460
-100.0%
40,082
-54.1%
0.00%0.0%
Q2 2022$923,000
-14.2%
87,260
+31.8%
0.00%0.0%
Q1 2022$1,076,000
+1663.9%
66,185
+1397.4%
0.00%
Q4 2021$61,000
-92.7%
4,420
-91.5%
0.00%
-100.0%
Q3 2021$841,000
+0.4%
51,735
-2.4%
0.00%0.0%
Q2 2021$838,00053,009
+33.0%
0.00%
Q1 2021$0
-100.0%
39,871
-84.1%
0.00%
-100.0%
Q4 2020$1,866,000
+1996.6%
250,512
+859.2%
0.00%
Q3 2020$89,000
+81.6%
26,118
+150.2%
0.00%
Q2 2020$49,000
+390.0%
10,439
+259.6%
0.00%
Q4 2019$10,000
-65.5%
2,903
-21.2%
0.00%
Q4 2018$29,000
-47.3%
3,682
-49.5%
0.00%
Q3 2018$55,000
-83.4%
7,298
-87.8%
0.00%
-100.0%
Q2 2017$331,000
+845.7%
59,614
+1315.3%
0.01%
+600.0%
Q1 2017$35,000
-82.8%
4,212
-86.9%
0.00%
-83.3%
Q4 2016$203,000
+66.4%
32,215
+16.2%
0.01%
+50.0%
Q3 2016$122,000
+3966.7%
27,729
+6849.6%
0.01%
Q1 2015$3,000
+50.0%
399
+173.3%
0.00%
Q4 2014$2,0001460.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders